Search Results

Bentley Launches BeGraft Plus Stent Graft Across Europe

January 31, 2018—Bentley announced the European launch of its BeGraft Plus covered balloon-expandable stent.

Bentley’s BeGraft Plus for BEVAR Used in First Clinical Procedure

December 3, 2025—Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeGraft Plus, which features a new 77/78-mm length.

Bentley’s Study of BeGraft Peripheral Bridging Stent in FEVAR Completes Enrollment

July 21, 2022—Germany-based Bentley InnoMed announced that recruitment has been completed in the BGP Stent as Bridging Stent in FEVAR study.

Bentley’s BeGraft and BeFlared Gain TÜV Certification as Bridging Stents for FEVAR

November 20, 2024—Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex aortic interventions in all countries that recognize CE Mark approval.

Study Seeks Evidence for On-Label Use of Bentley’s BeGraft Stent for FEVAR

March 19, 2021—Bentley InnoMed GmbH announced that the first patient to undergo fenestrated endovascular aortic repair (FEVAR) with the company’s BeGraft peripheral balloon-expandable covered stent was treated in the open-label BeGraft FEVAR study.

FDA Approves Gore C3 Delivery System

January 4, 2011—Gore & Associates (Flagstaff, AZ) announced that the company has received approval from the US Food and Drug Administration to market the Gore C3 delivery system to deploy the Gore Excluder AAA endoprosthesis for treating abdominal aortic aneurysms.

Bentley’s BeGraft Peripheral Stent Graft System Studied to Gain On-Label Indication for FEVAR

November 8, 2021—Bentley InnoMed GmbH announced that patient enrollment in a study of the safety and performance of the company’s BeGraft peripheral stent graft system as a dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR) procedures for complex aortic aneurysms.

Aptus Completes First EndoStapling Procedures in Europe

August 6, 2010—Aptus Endosystems, Inc. (Sunnyvale, CA) announced that the Aptus EndoStapling system was used for the first time in Europe to treat patients with aortic aneurysm disease.

Gore's C3 Delivery System for Excluder AAA Endoprosthesis Launched in Europe

September 16, 2010—W.

Aptus' Thoracic-Length Heli-FX Aortic Securement System Receives CE Mark Approval

April 2, 2013—Aptus Endosystems, Inc. (Sunnyvale, CA) announced that it has received CE Mark approval for its thoracic-length Heli-FX system, which is similar to the original Heli-FX system that was cleared for European distribution in May 2011 for the treatment of abdominal aortic aneurysms (AAA).

TriVascular's Ovation iX Abdominal Stent Graft System Introduced in Europe

September 15, 2015—TriVascular Technologies, Inc. announced that the first European patients have been treated successfully with the Ovation iX “integrated exchange” abdominal stent graft system at Herz- und Gefäßzentrum Bad Bevensen in Germany and Watford General Hospital in the United Kingdom.